reported that the SHARPIN gene is frequently amplified in approximately 20% of breast cancers, SHARPIN gene copy number amplification occurred in 403 tumors among 1980 breast cancer cases in the Curtis subdataset within the cBioPortal database, and the amplification was modestly associated with a decrease in OS in breast cancer patients (22). Here, SHARPIN is linked to breast cancer.